ProShare Advisors’s Adverum Biotechnologies ADVM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,644
| Closed | -$34K | – | 1793 |
|
|
2022
Q1 | $34K | Sell |
2,644
-636
| -19% | -$8.18K | ﹤0.01% | 2141 |
|
|
2021
Q4 | $57K | Buy |
3,280
+71
| +2% | +$1.23K | ﹤0.01% | 2268 |
|
|
2021
Q3 | $70K | Sell |
3,209
-804
| -20% | -$17.5K | ﹤0.01% | 1948 |
|
|
2021
Q2 | $140K | Buy |
4,013
+285
| +8% | +$9.94K | ﹤0.01% | 2231 |
|
|
2021
Q1 | $368K | Buy |
3,728
+252
| +7% | +$24.9K | ﹤0.01% | 1669 |
|
|
2020
Q4 | $377K | Buy |
3,476
+879
| +34% | +$95.3K | ﹤0.01% | 1450 |
|
|
2020
Q3 | $268K | Buy |
2,597
+321
| +14% | +$33.1K | ﹤0.01% | 1250 |
|
|
2020
Q2 | $475K | Buy |
2,276
+1,026
| +82% | +$214K | ﹤0.01% | 970 |
|
|
2020
Q1 | $122K | Sell |
1,250
-878
| -41% | -$85.7K | ﹤0.01% | 1058 |
|
|
2019
Q4 | $245K | Sell |
2,128
-232
| -10% | -$26.7K | ﹤0.01% | 1461 |
|
|
2019
Q3 | $129K | Sell |
2,360
-68
| -3% | -$3.72K | ﹤0.01% | 1516 |
|
|
2019
Q2 | $289K | Sell |
2,428
-300
| -11% | -$35.7K | ﹤0.01% | 1263 |
|
|
2019
Q1 | $143K | Buy |
2,728
+23
| +0.9% | +$1.21K | ﹤0.01% | 1532 |
|
|
2018
Q4 | $85K | Buy |
+2,705
| New | +$85K | ﹤0.01% | 1492 |
|
|
2016
Q4 | – | Sell |
-2,834
| Closed | -$116K | – | 1741 |
|
|
2016
Q3 | $116K | Sell |
2,834
-516
| -15% | -$21.1K | ﹤0.01% | 1407 |
|
|
2016
Q2 | $106K | Buy |
3,350
+1,217
| +57% | +$38.5K | ﹤0.01% | 1518 |
|
|
2016
Q1 | $110K | Sell |
2,133
-223
| -9% | -$11.5K | ﹤0.01% | 1507 |
|
|
2015
Q4 | $224K | Buy |
2,356
+211
| +10% | +$20.1K | ﹤0.01% | 1475 |
|
|
2015
Q3 | $177K | Sell |
2,145
-142
| -6% | -$11.7K | ﹤0.01% | 1333 |
|
|
2015
Q2 | $371K | Buy |
2,287
+114
| +5% | +$18.5K | 0.01% | 1220 |
|
|
2015
Q1 | $880K | Buy |
2,173
+537
| +33% | +$217K | 0.01% | 906 |
|
|
2014
Q4 | $883K | Buy |
+1,636
| New | +$883K | 0.01% | 920 |
|